Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung Cancer
Clinical trial NCT04012619 · COMPLETED
Trial details
- NCT number
- NCT04012619
- Sponsor
- Sichuan University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-30
- Primary completion
- 2019-11-05
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.